Drug Patent Expirations in March 2012

Drug Patent Expirations in March 2012

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
GEODONPfizerziprasidone mesylate4,831,031Mar 2, 2012
GEODONPfizer Incziprasidone hydrochloride4,831,031Mar 2, 2012
GEODONPfizerziprasidone hydrochloride4,831,031Mar 2, 2012
ZOFRANGlaxosmithklineondansetron hydrochloride5,344,658*PEDMar 6, 2012
GENESAGensia Automedicsarbutamine hydrochloride5,395,970Mar 7, 2012
NUTROPIN DEPOTGenentechsomatropin recombinant5,912,015Mar 12, 2012
LEXAPROForest Labsescitalopram oxalateRE34712*PEDMar 14, 2012
AVANDIASb Pharmcorosiglitazone maleate5,002,953*PEDMar 17, 2012
AVANDAMETSb Pharmcometformin hydrochloride; rosiglitazone maleate5,002,953*PEDMar 17, 2012
AVANDARYLSb Pharmcoglimepiride; rosiglitazone maleate5,002,953*PEDMar 17, 2012
BONIVARocheibandronate sodium4,927,814Mar 17, 2012
ERAXISVicuronanidulafungin6,384,013Mar 19, 2012
ERAXISVicuronanidulafungin6,743,777Mar 19, 2012
VALTURNANovartisaliskiren hemifumarate; valsartan5,399,578Mar 21, 2012
GABITRILCephalontiagabine hydrochloride5,354,760Mar 24, 2012
SEROQUELAstrazenecaquetiapine fumarate4,879,288*PEDMar 26, 2012
SEROQUEL XRAstrazenecaquetiapine fumarate4,879,288*PEDMar 26, 2012
NUEDEXTAAvanir Pharmsdextromethorphan hydrobromide; quinidine sulfate5,206,248Mar 27, 2012
FLOXIN OTICDaiichiofloxacin5,401,741Mar 27, 2012
AVALIDESanofi Aventishydrochlorothiazide; irbesartan5,270,317*PEDMar 30, 2012
AVAPROSanofi Aventis Usirbesartan5,270,317*PEDMar 30, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog